Navigation Links
Bayhill Therapeutics and the Juvenile Diabetes Research Foundation announce research collaboration
Date:10/30/2008

l milestones expected to be reached by the third quarter of 2009.

Through its IDDP program, JDRF has funded some 25 companies, representing approximately $29 million in diabetes science.

"Our partnership with Bayhill Therapeutics reflects JDRF's commitment to accelerating the pace of science leading to a cure for type 1 diabetes," said Dr. Richard A. Insel, JDRF Executive Vice President, Research. "Bayhill's DNA vaccine protocol has the potential to negate the autoimmune process causing type 1 diabetes, which must be addressed to cure the disease."

About T1D

Type 1 diabetes is an autoimmune disease that results from the immune system attacking and destroying insulin-producing cells in the pancreas. It affects children, adolescents, and adults, and last for life. Tight control of blood glucose is critical to both the long- and short-term health of patients. Short-term effects of poor glucose control include diabetic ketoacidosis, which is a condition that can lead to coma. Long-term effects include elevated glucose levels, blindness, kidney disease, heart disease, peripheral vascular disease and stroke. In order to keep blood glucose at or near normal levels, patients require the life-long administration of insulin, which is the only approved therapy for type 1 diabetes.

About BHT-3021

BHT-3021 is a plasmid encoding proinsulin designed to tolerize the immune system, thereby turning off the self directed immune attack against the islet cells. This product candidate's potential to stabilize or improve glucose control by eliminating the autoimmune response could lead to reduced insulin dependence and long-term complications of type 1 diabetes.

Patient enrollment is currently underway in a Phase I/II placebo-controlled clinical trial of BHT-3021 to evaluate safety, pharmacodynamics, immune tolerance and pancreatic function in patients with T1D. Preliminary data from the trial have been pos
'/>"/>

Contact: Leslie Schwartz
lschwartz@jdrf.org
212-479-7553
Juvenile Diabetes Research Foundation International
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Galapagos and Cystic Fibrosis Foundation Therapeutics announce drug discovery collaboration
2. Michael J. Fox Foundation PD Therapeutics Conference
3. CU-Boulder, biotech firm team up on python project in search for human cardiac therapeutics
4. Media invitation: 20th EORTC-NCI-ACR Symposium on Molecular Targets and Cancer Therapeutics
5. Sirtris review of sirtuin therapeutics for diseases of aging in Nature Reviews Drug Discovery
6. Growing fuel and medicine: Advancing biofuels and plant-produced therapeutics
7. Scientists show that mitochondrial DNA variants are linked to risk factors for type 2 diabetes
8. Gender, coupled with diabetes, affects vascular disease development
9. Breakthrough research identifies how cells from pigs may cure diabetes
10. Botched production of insulin molecule may lead to diabetes
11. Joslin researchers uncover potential role of leptin in diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... As of 2015, Springer will publish the International ... official journal of the Taiwan Fuzzy Systems Association (TFSA). ... global visibility in the area of fuzzy research., The ... to presenting high-quality papers that deal with the theory, ... gray systems and extension theory systems ranging from hardware ...
(Date:7/23/2014)... , July 23, 2014   MedNet ... specializing in clinical study management systems, is pleased ... a proven life sciences industry executive with over ... Operating Officer (COO).  Clareece will be responsible for ... growth, operational efficiency and quality product/service delivery.  ...
(Date:7/23/2014)... Streptococcus mutans , one of the principal bacteria ... in its genetic material over time, possibly coinciding ... humanity. This is highlighted in a study ... (UAB) and the Laboratorio Nacional de Genmica para ... in Mexico who, for the first time, have ...
Breaking Biology News(10 mins):MedNet Appoints Clareece West As Chief Operating Officer 2Ancient genetic material from caries bacterium obtained for the first time 2
... (NASDAQ: MASI ) today announced that its management ... Health Care Conference at the New York Palace Hotel in New York ... A live audiocast of the presentation will be available on ... the audiocast will be available following the live presentation. ...
... have suggested that climate change is causing additional stress to ... consider a significant reduction, or in some places elimination of ... growing degradation of grazing lands could be mitigated if large ... lands became free of use by livestock and "feral ungulates" ...
... CINCINNATIA University of Cincinnati (UC) Cancer Institute lung cancer ... be isolatedand then grownin a preclinical model, offering a ... target stem cells. John C. Morris, MD, ... 13, 2012, issue of PLOS One , a ...
Cached Biology News:Masimo to Present at 24th Annual Piper Jaffray Health Care Conference 2Masimo to Present at 24th Annual Piper Jaffray Health Care Conference 3Climate change increases stress, need for restoration on grazed public lands 2Climate change increases stress, need for restoration on grazed public lands 3Stem cell finding could advance immunotherapy for lung cancer 2
(Date:7/23/2014)... 2014 Shire plc (LSE: ... specialty biopharmaceutical company, and ArmaGen, a US privately ... and collaboration agreement for AGT-182, an investigational enzyme ... both the central nervous system (CNS) and somatic ... This collaboration strengthens Shire,s rare disease pipeline of ...
(Date:7/23/2014)... July 23, 2014 With the ability to ... resolution for more than 15 minutes, Fastec Imaging has brought ... of high speed imaging. “Finally, a high speed camera that ... use in our everyday lives.” proclaims Matt Kearney, VP of ... always been to demystify and simplify the traditionally complicated workflow ...
(Date:7/23/2014)... 23, 2014 Astra Nova ... comprehensive consultancy and pharma training services, and the ... (ACRES) , a non-profit integrating the expertise and ... maintain a global system for clinical trials, are ... improve the expertise of industry professionals through improved ...
(Date:7/22/2014)... National Institute of Standards and Technology (NIST) and ... new design for an atomic clock that is ... microcomb. , The microcomb clock, featured on the ... journal Optica ,* is the first demonstration ... accurate conversion of optical frequencies to lower microwave ...
Breaking Biology Technology:Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 2Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 3Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 4Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 5Fastec Imaging Introduces the First High Speed Camcorder 2Fastec Imaging Introduces the First High Speed Camcorder 3Astra Nova and ACRES Partner on Quality and Access of Training for Research Professionals 2Astra Nova and ACRES Partner on Quality and Access of Training for Research Professionals 3'Comb on a chip' powers new NIST/Caltech atomic clock design 2
... Inc. (NYSE Amex: PIP ), a biodefense ... announced today that results from a second Phase II ... Annual Conference on Vaccine Research, being held in Baltimore, ... the National Foundation of Infectious Diseases.David P. Wright, President ...
... 28 Techne Corporation (Nasdaq: TECH ) announced ... dividend of $0.25 per share for the quarter ended March ... 22, 2009 to all common shareholders of record on May ... the Board of Directors on a quarterly basis.Techne,s Board of ...
... for Mycobacterium tuberculosis (TB) Expected to Highlight Broad On-Demand ... 28 Cepheid (Nasdaq: CPHD ) today ... Patient Management in the Era of Rapid Diagnostics ," ... Congress of Clinical Microbiology and Infectious Diseases (ECCMID), taking ...
Cached Biology Technology:PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research 2PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research 3PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research 4PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research 5PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research 6PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research 7Techne Corporation Declares Dividend and Announces an Increase in Its Share Repurchase Program 2Cepheid Announces Symposium Speakers and Program Highlights for 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2Cepheid Announces Symposium Speakers and Program Highlights for 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 3Cepheid Announces Symposium Speakers and Program Highlights for 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 4Cepheid Announces Symposium Speakers and Program Highlights for 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 5
... is a type I eukaryotic topoisomerase that ... (also called right- and left-handed supercoils) from ... reaction is a covalently closed, circular DNA ... DNA Topoisomerase I does not absolutely require ...
... DNA Modification Kit contains reagents required to ... sample. In the bisulfite reaction, all unmethylated ... to uracils, while 5-methylcytosines remain unaltered. Thus, ... differ depending on whether the DNA is ...
... EnzChek Pyrophosphate Detection Kit,provides a fast, ... the inorganic pyrophosphate (PPi ) produced,by ... as DNA and,RNA polymerizations, cyclic AMP ... the enzymatic activation of fatty acids ...
... Premixed solution for high PCR specificity ... the combination of enzyme with unique ... nonspecific amplification provided by the ... handling convenient Master Mix and ...
Biology Products: